| Literature DB >> 20505799 |
Abstract
Insulin infusion has been advocated in the treatment of myocardial ischaemia and myocardial infarction. There is evidence from experimental animal studies for a protective effect of high-dose insulin administration in myocardial ischaemia and myocardial infarction. In some relatively small study populations a reduction in mortality was reported in those patients who received glucose-insulin-potassium (GIK) during myocardial infarction, which was confirmed in two meta-analyses. However, it has not been possible to reproduce these positive results in large randomised clinical trials. (Neth Heart J 2010;18:255-9.).Entities:
Keywords: Cardiomyopathy; Founder Effect; Mutation; Myosin-binding Protein C
Year: 2010 PMID: 20505799 PMCID: PMC2871746 DOI: 10.1007/BF03091772
Source DB: PubMed Journal: Neth Heart J ISSN: 1568-5888 Impact factor: 2.380